The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD

Nature Reviews Nephrology, Published online: 11 July 2019; doi:10.1038/s41581-019-0174-zThis Perspectives article considers why clinical trials of urate-lowering therapy (ULT) have shown inconsistent renoprotective effects in patients with chronic kidney disease, and suggests that sufficient evidence exists to support the use of routine screening for hyperuricaemia and initiation of ULT in selected patients.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Source Type: research